CGN Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.74M | Buy |
3,510
+161
| +5% | +$126K | 0.24% | 88 |
|
|
2025
Q1 | $2.77M | Sell |
3,349
-850
| -20% | -$702K | 0.27% | 85 |
|
|
2024
Q4 | $3.24M | Buy |
4,199
+1,040
| +33% | +$803K | 0.32% | 71 |
|
|
2024
Q3 | $2.8M | Buy |
3,159
+442
| +16% | +$392K | 0.28% | 86 |
|
|
2024
Q2 | $2.46M | Buy |
2,717
+1,716
| +171% | +$1.55M | 0.29% | 90 |
|
|
2024
Q1 | $779K | Buy |
1,001
+14
| +1% | +$10.9K | 0.1% | 159 |
|
|
2023
Q4 | $575K | Sell |
987
-310
| -24% | -$181K | 0.08% | 172 |
|
|
2023
Q3 | $697K | Buy |
1,297
+501
| +63% | +$269K | 0.09% | 166 |
|
|
2023
Q2 | $373K | Sell |
796
-26
| -3% | -$12.2K | 0.05% | 182 |
|
|
2023
Q1 | $282K | Hold |
822
| – | – | 0.04% | 198 |
|
|
2022
Q4 | $301K | Hold |
822
| – | – | 0.05% | 187 |
|
|
2022
Q3 | $266K | Buy |
822
+59
| +8% | +$19.1K | 0.07% | 201 |
|
|
2022
Q2 | $247K | Buy |
763
+18
| +2% | +$5.83K | 0.07% | 192 |
|
|
2022
Q1 | $213K | Sell |
745
-38
| -5% | -$10.9K | 0.05% | 210 |
|
|
2021
Q4 | $216K | Buy |
+783
| New | +$216K | 0.06% | 203 |
|
|
2021
Q3 | – | Sell |
-1,795
| Closed | -$412K | – | 202 |
|
|
2021
Q2 | $412K | Sell |
1,795
-26
| -1% | -$5.97K | 0.13% | 151 |
|
|
2021
Q1 | $340K | Buy |
1,821
+62
| +4% | +$11.6K | 0.12% | 153 |
|
|
2020
Q4 | $297K | Buy |
+1,759
| New | +$297K | 0.12% | 156 |
|